Literature DB >> 23368766

Impaired cytoplasmic-nuclear transport of hypoxia-inducible factor-1α in amyotrophic lateral sclerosis.

Yuko Nagara1, Takahisa Tateishi, Ryo Yamasaki, Shintaro Hayashi, Mami Kawamura, Hitoshi Kikuchi, Kyoko Motomura Iinuma, Masahito Tanaka, Toru Iwaki, Takuya Matsushita, Yasumasa Ohyagi, Jun-ichi Kira.   

Abstract

We investigated the mechanisms underlying abnormal vascular endothelial growth factor (VEGF) production in amyotrophic lateral sclerosis (ALS). We immunohistochemically studied VEGF, its receptors VEGFR1 and 2, and hypoxia-inducible factor-1α (HIF-1α) in autopsied ALS spinal cords. We also chronologically assessed the expression of HIF-1α, karyopherin β1, karyopherin β-cargo protein complex inhibitors and nuclear pore complex proteins in G93A mutant superoxide dismutase 1 (mSOD1) transgenic mice at presymptomatic, symptomatic and end stages. In ALS patients, compared with controls, HIF-1α immunoreactivity in the cytoplasm of anterior horn cells (AHCs) was significantly increased, while immunoreactivities for VEGF and VEGFRs were significantly decreased. Similar changes in HIF-1α and VEGF levels were observed in mSOD1 transgenic mice. HIF-1α co-localized with karyopherin β1 in the cytoplasm of AHCs and karyopherin β1 co-localized with nucleoporin 62 (Nup62) on the nuclear envelope. From the presymptomatic stage of mSOD1 transgenic mice, karyopherin β1 immunoreactivity in AHC nuclei significantly decreased and morphological irregularities of the Nup62-immunostained nuclear envelope became more pronounced with disease progression. Thus, in AHCs from mSOD1 transgenic mice, transport of cytoplasmic HIF-1α to the nuclear envelope and into the nucleus is impaired from the presymptomatic stage, suggesting that impaired cytoplasmic-nuclear transport of HIF-1α through the nuclear pore might precede motor neuron degeneration.
© 2013 International Society of Neuropathology.

Entities:  

Keywords:  amyotrophic lateral sclerosis; hypoxia-inducible factor-1α; impaired cytoplasmic-nuclear transport; mutant superoxide dismutase 1; vascular endothelial growth factor

Mesh:

Substances:

Year:  2013        PMID: 23368766     DOI: 10.1111/bpa.12040

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  21 in total

Review 1.  The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration.

Authors:  Paulo A Ferreira
Journal:  Cell Mol Life Sci       Date:  2019-02-11       Impact factor: 9.261

2.  Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.

Authors:  Kyoung-In Cho; Dosuk Yoon; Minzhong Yu; Neal S Peachey; Paulo A Ferreira
Journal:  Cell Mol Life Sci       Date:  2019-04-03       Impact factor: 9.261

3.  Fluorescence-based quantification of nucleocytoplasmic transport.

Authors:  Joshua B Kelley; Bryce M Paschal
Journal:  Methods       Date:  2018-11-10       Impact factor: 3.608

Review 4.  Nuclear-cytoplasmatic shuttling of proteins in control of cellular oxygen sensing.

Authors:  Reinhard Depping; Wolfgang Jelkmann; Friederike Katharina Kosyna
Journal:  J Mol Med (Berl)       Date:  2015-03-27       Impact factor: 4.599

Review 5.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

Review 6.  Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD.

Authors:  Claudia Fallini; Bilal Khalil; Courtney L Smith; Wilfried Rossoll
Journal:  Neurobiol Dis       Date:  2020-03-14       Impact factor: 5.996

7.  Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.

Authors:  Takafumi Mashiko; Eiji Sakashita; Katsumi Kasashima; Kaoru Tominaga; Kenji Kuroiwa; Yasuyuki Nozaki; Tohru Matsuura; Toshiro Hamamoto; Hitoshi Endo
Journal:  J Biol Chem       Date:  2016-05-12       Impact factor: 5.157

Review 8.  Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?

Authors:  Peter Göttle; Patrick Küry
Journal:  Int J Mol Sci       Date:  2015-07-03       Impact factor: 5.923

9.  Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination.

Authors:  Jeffery D Haines; Olivier Herbin; Belén de la Hera; Oscar G Vidaurre; Gregory A Moy; Qingxiang Sun; Ho Yee Joyce Fung; Stefanie Albrecht; Konstantina Alexandropoulos; Dilara McCauley; Yuh Min Chook; Tanja Kuhlmann; Grahame J Kidd; Sharon Shacham; Patrizia Casaccia
Journal:  Nat Neurosci       Date:  2015-02-23       Impact factor: 24.884

Review 10.  Trophic factors as modulators of motor neuron physiology and survival: implications for ALS therapy.

Authors:  Luis B Tovar-Y-Romo; Uri Nimrod Ramírez-Jarquín; Rafael Lazo-Gómez; Ricardo Tapia
Journal:  Front Cell Neurosci       Date:  2014-02-28       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.